BRIEF-Theravance Biopharma Announces Approval Of Yupelri By China's NMPA

Reuters
26 Jun
BRIEF-Theravance Biopharma Announces Approval Of Yupelri By China's NMPA

June 26 (Reuters) - Theravance Biopharma Inc TBPH.O:

  • THERAVANCE BIOPHARMA ANNOUNCES APPROVAL OF YUPELRI® (REVEFENACIN) BY CHINA'S NMPA

  • THERAVANCE BIOPHARMA INC - APPROVAL TRIGGERS $7.5 MILLION MILESTONE PAYMENT FROM VIATRIS

Source text: ID:nPn4vc42Wa

Further company coverage: TBPH.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10